1 / 7

Malaria Vaccines Market

According to the World Malaria Report published by WHO in November 2018, the cases for malaria were 219 million in 2017 in more than 90 countries which were up from 217 million cases in 2017. The total deaths due to malaria in 2017 were 435,000 which were registered in the malaria affected regions.

Ronald15
Download Presentation

Malaria Vaccines Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Malaria Vaccines Market Market Size Worth $134.9 Million By 2026 | CAGR 33.2%

  2. Malaria Vaccines Market Size Worth $ 134.9 Million By 2026 | CAGR 33.2% “As per Polaris Market Research report, Malaria Vaccines Market is attending major innovations & transformations and is projected to reach $134.9 Million By 2026 | CAGR 33.2% during the conjecture period 2019 to 2026.” The global Malaria Vaccines Market report scrutinizes the present situation and development prognosis of the market. The report offers a complete knowledge of key parameters such as market size, share and growth, trends, cost structure, and comprehensive and statistical data in the global Malaria Vaccines Market. Also, the market overview section of the report holds an in-depth analysis of current and future trends, analyzing the data on a historical basis and forecasted data till the year 2026. The report traces key market drivers, covering potentially lucrative opportunities and challenges as well as drivers, obstacles, issues, and risks. ➢Malaria Vaccines Market Report Scope: The global Malaria Vaccines Market is segmented ByAgent Type, By Vaccine Type, By Distribution Channel, By Region. The research report analyzes the most important trends related to the different segments that help to explain the market. The report additionally surveys both developed & developing regions considered for global Malaria Vaccines Market research. The regional analysis engages readers with a comprehensive overview of various countries and regions to help players plan effective expansion strategies. The report outlines the noteworthy factors, such as driving factors and challenges, that will explain the market’s future growth. Also, it covers an exhaustive coverage of major industry drivers, restraints, and their impact on global Malaria Vaccines Market growth during the forecast period from 2019-2026. The market research assists in studying the key plans, initiatives, and strategies for the development of the market. - 2 -

  3. Malaria Vaccines Market Size Worth $ 134.9 Million By 2026 | CAGR 33.2% ByAgent Type By Vaccine Type By Distribution Channel By Region •Plasmodium Falciparum •Plasmodium Vivax •Pre-Erythrocytic Vaccine •Hospitals •North America (U.S., Canada) •Erythrocytic Vaccine •Clinics •Europe (Germany, UK, France, Italy, Spain, •Multi-antigen Vaccine •Community Belgium, Russia, Netherlands) •Anopheles •Asia-Pacific (China, Japan, India, Australia, Korea, Centers Species Singapore, Malaysia, Indonesia, Thailand, Philippines) •Latin America (Brazil, Mexico, Argentina) •Middle East and Africa (UAE, Saudi Arabia, South Africa) ➢COVID-19 Impact Analysis for Malaria Vaccines Market The market has also been affected by the recent COVID-19 pandemic and is expected to experience its long- term effects over the forecast period. Extensive evaluation of the effect of the COVID-19 pandemic is given to uncover the major issues and potential paths forward. The report merges the customer spending habits, business target, dynamics of current market forces, re-routing of the supply chain, and competitors in the global Malaria Vaccines Market as a thorough analysis. The report serves overall estimation, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Malaria Vaccines Market across different regions and how major players are building strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities ➢Regional Outlook In terms of geography, the region dominated the market with its higher revenue share contribution. The driving factors for this regional market growth include the current technological advancements in the industry, growing economic stability, huge government investments, and rising awareness related to the benefits of the product/service. ➢Browse Detailed Research Report on Malaria Vaccines Market Analysis: https://www.polarismarketresearch.com/industry-analysis/malaria-vaccines-market ➢Competitive Landscape The report completely profiles prominent market players or industrialists covering company profile, product specifications, production capacity/sales, revenue, price, and gross margin & sales. Here you will find a - 3 -

  4. Malaria Vaccines Market Size Worth $ 134.9 Million By 2026 | CAGR 33.2% comprehensive analysis of the competitive landscape and detailed information on vendors and factors that will challenge the growth of major vendors. The section highlights key points such as regional segmentation, major investments, and details of historical, present, and projected revenues. the product portfolio, market explanation, and classification are indicated. According to Polaris Market Research, the leading players with a noteworthy dominance in the Malaria Vaccines Market include GlaxoSmithKline, Nobelpharma,and Sanaria. Other promising vendors are Cadila Healthcare Ltd., VLP Therapeutics LLC, CellFree Sciences Co. Ltd., and Genome ReS Ltd. https://www.polarismarketresearch.com/industry-analysis/malaria-vaccines- Request for sample: market/request-for-sample Table of Contents 1.Overview and Scope 1.1.Research goal & scope 1.2.Research assumptions 1.3.Research Methodology 1.3.1.Primary data sources 1.3.2.Secondary data sources 1.4.Key take-away 1.5.Stakeholders 2.Executive Summary 2.1.Market Definition 2.2.Market Segmentation 3.Malaria Vaccines Market Insights 3.1.Malaria Vaccines– Industry snapshot 3.2.Malaria Vaccines-Ecosystem analysis 3.3.Malaria Vaccines market dynamics 3.3.1.Malaria Vaccines– Market Forces 3.3.1.1. Malaria Vaccines Market driver analysis 3.3.1.2. Malaria Vaccines Market restraint/challenges analysis 3.3.1.3. Malaria Vaccines Market opportunity analysis 3.4.Industry analysis - Porter's five force 3.4.1.Bargaining power of supplier 3.4.2.Bargaining power of buyer 3.4.3.Threat of substitute 3.4.4.Threat of new entrant 3.4.5.Degree of competition 3.5.Malaria Vaccines market PEST analysis, 2017 3.6.Malaria Vaccines market Value Chain analysis 3.7.Malaria Vaccines Industry trends 3.8.Competitive Ranking Analysis 4.Malaria Vaccines Market Size and Forecast by Agent 4.1.Key Findings 4.2.Plasmodium Falciparum 4.2.1.Global Market Estimates and Forecasts, 2017-2026 - 4 -

  5. Malaria Vaccines Market Size Worth $ 134.9 Million By 2026 | CAGR 33.2% 4.3.Plasmodium Vivax 4.3.1.Global Market Estimates and Forecasts, 2017-2026 4.4.Anopheles Species 4.4.1.Global Market Estimates and Forecasts, 2017-2026 5.Malaria Vaccines Market Size and Forecast by Vaccines Type 5.1.Key Findings 5.2.Pre-Erythrocytic Vaccine 5.2.1.Global Market Estimates and Forecasts, 2017-2026 5.3.Erythrocytic Vaccine 5.3.1.Global Market Estimates and Forecasts, 2017-2026 5.4.Multi-antigen Vaccine 5.4.1.Global Market Estimates and Forecasts, 2017-2026 6.Malaria Vaccines Market Size and Forecast by Channel of Distribution 6.1.Key Findings 6.2.Hospitals 6.2.1.Global Market Estimates and Forecasts, 2017-2026 6.3.Clinics 6.3.1.Global Market Estimates and Forecasts, 2017-2026 6.4.Community Centers 6.4.1.Global Market Estimates and Forecasts, 2017-2026 7.Malaria Vaccines Market Size and Forecast by Regions 7.1.Key findings 7.2.North America 7.2.1.Malaria Vaccines market by Agent, 2017 - 2026 7.2.2.Malaria Vaccines market by Vaccines Type, 2017 - 2026 7.2.3.Malaria Vaccines market by Channel of Distribution, 2017 - 2026 7.2.4.U.S. 7.2.4.1. Malaria Vaccines market by Agent, 2017 - 2026 7.2.4.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 7.2.4.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 7.2.5.Canada 7.2.5.1. Malaria Vaccines market by Agent, 2017 - 2026 7.2.5.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 7.2.5.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 7.3.Europe 7.3.1.Malaria Vaccines market by Agent, 2017 - 2026 7.3.2.Malaria Vaccines market by Vaccines Type, 2017 - 2026 7.3.3.Malaria Vaccines market by Channel of Distribution, 2017 - 2026 7.3.4.Germany 7.3.4.1. Malaria Vaccines market by Agent, 2017 - 2026 7.3.4.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 7.3.4.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8. 8.1. 8.1.1.UK 8.1.1.1. Malaria Vaccines market by Agent, 2017 - 2026 8.1.1.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 8.1.1.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8.1.2.France 8.1.2.1. Malaria Vaccines market by Agent, 2017 - 2026 - 5 -

  6. Malaria Vaccines Market Size Worth $ 134.9 Million By 2026 | CAGR 33.2% 8.1.2.2. 8.1.2.3. 8.1.3.Asia Pacific 8.1.3.1. 8.1.3.2. 8.1.3.3. 8.1.4.China 8.1.4.1. 8.1.4.2. 8.1.4.3. 8.1.5.India 8.1.5.1. 8.1.5.2. 8.1.5.3. 8.1.6.Japan 8.1.6.1. 8.1.6.2. 8.1.6.3. 8.2.Latin America 8.2.1.Malaria Vaccines market by Agent, 2017 - 2026 8.2.2.Malaria Vaccines market by Vaccines Type, 2017 - 2026 8.2.3.Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8.2.4.Brazil 8.2.4.1. Malaria Vaccines market by Agent, 2017 - 2026 8.2.4.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 8.2.4.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8.2.5.Mexico 8.2.5.1. Malaria Vaccines market by Agent, 2017 - 2026 8.2.5.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 8.2.5.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8.3.Middle East & Africa 8.3.1.Malaria Vaccines market by Agent, 2017 - 2026 8.3.2.Malaria Vaccines market by Vaccines Type, 2017 - 2026 8.3.3.Malaria Vaccines market by Channel of Distribution, 2017 - 2026 9.Company Profiles 9.1.GlaxoSmithKline 9.1.1.Overview 9.1.2.Financials 9.1.3.Product Benchmarking 9.1.4.Recent Developments 9.2.Nobelpharma 9.2.1.Overview 9.2.2.Financials 9.2.3.Product Benchmarking 9.2.4.Recent Developments 9.3.Sanaria 9.3.1.Overview 9.3.2.Financials 9.3.3.Product Benchmarking 9.3.4.Recent Developments Malaria Vaccines market by Vaccines Type, 2017 - 2026 Malaria Vaccines market by Channel of Distribution, 2017 - 2026 Malaria Vaccines market by Agent, 2017 - 2026 Malaria Vaccines market by Vaccines Type, 2017 - 2026 Malaria Vaccines market by Channel of Distribution, 2017 - 2026 Malaria Vaccines market by Agent, 2017 - 2026 Malaria Vaccines market by Vaccines Type, 2017 - 2026 Malaria Vaccines market by Channel of Distribution, 2017 - 2026 Malaria Vaccines market by Agent, 2017 - 2026 Malaria Vaccines market by Vaccines Type, 2017 - 2026 Malaria Vaccines market by Channel of Distribution, 2017 - 2026 Malaria Vaccines market by Agent, 2017 - 2026 Malaria Vaccines market by Vaccines Type, 2017 - 2026 Malaria Vaccines market by Channel of Distribution, 2017 - 2026 - 6 -

  7. Malaria Vaccines Market Size Worth $ 134.9 Million By 2026 | CAGR 33.2% 9.4.Cadila Healthcare Ltd. 9.4.1.Overview 9.4.2.Financials 9.4.3.Product Benchmarking 9.4.4.Recent Developments 9.5.VLP Therapeutics LLC 9.5.1.Overview 9.5.2.Financials 9.5.3.Product Benchmarking 9.5.4.Recent Developments 9.6.CellFree Sciences Co. Ltd. 9.6.1.Overview 9.6.2.Financials 9.6.3.Product Benchmarking 9.6.4.Recent Developments 9.7.Genome ReS Ltd. 9.7.1.Overview 9.7.2.Financials 9.7.3.Product Benchmarking 9.7.4.Recent Developments ➢Access Press Release on Malaria Vaccines Market: https://www.polarismarketresearch.com/press-releases/malaria-vaccines-market ➢About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 7 -

More Related